Tezspire (tezepelumab or tezepelumab-ekko) is one of the available biologics for treating asthma. It's approved for people 12 years and older with severe asthma that's not controlled by other medications. Tezspire (tezepelumab) is an injection that's given under the skin once per month by a healthcare professional (HCP). There's also a prefilled pen for Tezspire (tezepelumab) that you can use at home after proper training from an HCP. Side effects aren't common but can include joint and back pain.
Tezspire (tezepelumab) is a biologic called a thymic stromal lymphopoietin (TSLP) blocker. It attaches to the TSLP protein, which is involved in causing airway inflammation in asthma. By attaching to this protein, Tezspire (tezepelumab) blocks it from working. This helps lower inflammation in your airways and better control your asthma.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Tips on how to use the Tezspire (tezepelumab) pen at home:
In a year-long study, people who took Tezspire (tezepelumab) in addition to other asthma medications had overall about 70% fewer asthma attacks per year than those who didn't get an add-on treatment. These included asthma attacks that could require hospitalization. People who took Tezspire (tezepelumab) for a year also had better breathing and lung function than those who didn't get additional treatment. Discuss with your asthma specialist if Tezspire (tezepelumab) is right for you. Speak with your prescriber about how well Tezspire (tezepelumab) is working for your asthma if you're already taking the medication,
A study showed that some people started to breathe better within 2 weeks of starting Tezspire (tezepelumab). In the same study, researchers found that this matches the time it takes for the medication to start lowering the amount of proteins that tend to cause inflammation and contribute to asthma symptoms. Speak to your prescriber if you're concerned with how well Tezspire (tezepelumab) is working for you.
Ask your prescriber whether it's okay for you to give yourself Tezspire (tezepelumab) injections at home. Your prescriber will most likely inject the medication at their office when you first start treatment. Depending on how comfortable you are, your prescriber might train you to give yourself the injections at home. They also might decide that it's better for you to get them at a clinic or medical office. Tezspire (tezepelumab) vials and prefilled syringes are only for injections given by a healthcare professional, but Tezspire (tezepelumab) prefilled pens are available for easy use at home.
No, Tezspire (tezepelumab) isn't a steroid; it's a biologic. Both Tezspire (tezepelumab) and steroid medications work to lower inflammation, but they do so in different ways. Your asthma specialist might consider adding Tezspire (tezepelumab) to your maintenance steroid inhaler if you still need more control of your asthma symptoms.
Both Tezspire (tezepelumab) and Dupixent (dupilumab) are biologics for asthma that are injections. Tezspire is approved for children ages 12 years an older, whereas Dupixent is approved for children ages 6 years and older. Tezspire is injected once per month; Dupixent is injected every 2 weeks for people 12 years and older (though younger children can get Dupixent once per month). While both medications haven't been compared to each other, a indirect comparison study found that Tezspire (tezepelumab) tends to lower the number of asthma attacks per year more than other asthma biologics like Dupixent. Ask your asthma specialist if you have more questions about comparing the two medications.
People didn't report changes in weight after they started treatment with Tezspire (tezepelumab) in clinical trials. Speak with your healthcare team if you experience unusual weight changes while you're taking Tezspire (tezepelumab).
Hair loss wasn't a side effect reported by people who took Tezspire (tezepelumab) in clinical trials. Speak with your prescriber if you notice hair loss while you're taking this medication so they can examine you for possible causes.
Fatigue wasn't a side effect that was reported by people who took Tezspire (tezepelumab) in clinical trials. Keep in mind that fatigue and lack of energy can be symptoms of asthma. It's best to touch base with your asthma specialist or primary care provider if you notice that you're more fatigued than usual. They might want to see how well controlled your asthma is.
Tezspire (tezepelumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Severe allergic reactions to Tezspire (tezepelumab) are possible, including life-threatening reactions like facial swelling and anaphylaxis (closing of the throat). These reactions can happen at any time during treatment (within hours or days after injecting). Get medical attention right away if you notice dizziness, a choking sensation, difficulty breathing, nausea, swelling around your eyes, or swelling of the lips or tongue after you take Tezspire (tezepelumab).
Your body's immune response to parasitic (worm) infections might involve the same protein that Tezspire (tezepelumab) blocks. Clinical studies for Tezspire (tezepelumab) didn't include people with parasitic infections. So it's not known whether your body will respond differently to a parasitic infection while you're taking Tezspire (tezepelumab). Let your prescriber know if you have a known parasitic infection before you start Tezspire (tezepelumab) because you'll need to receive treatment for it first.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 210mg of 210mg/1.91ml | 1 pen | $4,718.83 | $4,718.83 |
The typical dose is 210 mg injected under the skin once every month.